China Development Industrial Bank (CDIB)
Taiwan, Taiwan
63
107M
50
0.97
6
0.21
26
- Stages of investment
- Areas of investment
Summary
China Development Industrial Bank (CDIB) appeared to be the Corporate Investor, which was created in 1959. The leading representative office of defined Corporate Investor is situated in the Taipei. The fund was located in Asia if to be more exact in Taiwan.
The fund was created by Steven Chang. The overall number of key employees were 3.
The fund is constantly included in 2-6 investment rounds annually. Opposing the other organizations, this China Development Industrial Bank (CDIB) works on 13 percentage points more the average amount of lead investments. The top activity for fund was in 2001. When the investment is from China Development Industrial Bank (CDIB) the average startup value is more than 1 billion dollars. The common things for fund are deals in the range of more than 100 millions dollars. The real fund results show that this Corporate Investor is 4 percentage points less often commits exit comparing to other companies. The top amount of exits for fund were in 2007.
The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the China Development Industrial Bank (CDIB), startups are often financed by Venrock, U.S. Venture Partners (USVP), Mayfield Fund. The meaningful sponsors for the fund in investment in the same round are Venrock, U.S. Venture Partners (USVP), Mayfield Fund. In the next rounds fund is usually obtained by Venrock, U.S. Venture Partners (USVP), Mayfield Fund.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in some founders of portfolio startups. If startup sums 3 of the founder, the chance for it to be financed is low. Among the most successful fund investment fields, there are Medical, Health Care. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Ant Financial, WebEx, Santarus.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 63
- Lead investments
- 6
- Exits
- 26
- Rounds per year
- 0.97
- Follow on index
- 0.21
- Investments by industry
- Biotechnology (21)
- Pharmaceutical (13)
- Health Care (13)
- Medical (11)
- Semiconductor (9) Show 73 more
- Investments by region
-
- China (5)
- United States (46)
- Taiwan (8)
- Israel (2)
- Peak activity year
- 2001
- Number of Unicorns
- 2
- Number of Decacorns
- 3
- Number of Minotaurs
- 4
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 19
- Avg. valuation at time of investment
- 2B
- Group Appearance index
- 0.94
- Avg. company exit year
- 11
- Avg. multiplicator
- 1.50
- Strategy success index
- 0.70
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| AnBogen Therapeutics | 31 Jan 2024 | Biotechnology, Medical | Early Stage Venture | 12M | Taitung County, Taiwan, Taiwan |
| Kaixin Dai | 30 Sep 2015 | Financial Services, FinTech, Payments, Consumer Lending | Seed | 34M | Jiangsu, Xuanwu District, China |
| Toptal | 01 Jul 2012 | Software, Human Resources, SaaS, Software Engineering, Product Design | Seed | 0 | United States, California, San Francisco |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.